Mitochondrial Fission in Neurodegeneration

Overview

Mitochondrial Fission in Neurodegeneration describes a key molecular or cellular mechanism implicated in neurodegenerative disease. This page provides a detailed overview of the pathway components, signaling cascades, and their relevance to conditions such as Alzheimer’s disease, Parkinson’s disease, and related disorders. ^{1Abnormal mitochondrial dynamics, mitochondrial fission and fusion in neurodegenerative diseases2011 · Experimental Neurology · PMID 21892499Open reference}

Mitochondrial fission is the process by which mitochondria divide and fragment from an interconnected network into discrete organelles[1]. This dynamic process is essential for mitochondrial quality control, enabling the removal of damaged mitochondrial segments via mitophagy, distribution of mitochondria within neurons, and adaptation to metabolic demands. Dysregulation of fission contributes to mitochondrial dysfunction, bioenergetic failure, and neuronal death in neurodegenerative diseases.

Molecular Machinery of Mitochondrial Fission

DRP1 (Dynamin-Related Protein 1)

• Cytosolic GTPase that translocates to mitochondria during fission

• Forms ring-like structures around mitochondria constricting the membranes[1]

• Recruited by adaptor proteins on the outer mitochondrial membrane

• Post-translational modifications regulate its activity (phosphorylation, sumoylation, ubiquitination)

Fission Proteins (FIS1, MFF, MiD49, MiD50)

• FIS1: Outer membrane protein serving as DRP1 receptor

• MFF: Primary DRP1 receptor, essential for peroxisomal and mitochondrial fission

• MiD49/MiD50: Additional DRP1 receptors with tissue-specific expression

Endoplasmic Reticulum Contacts

• ER tubules wrap around mitochondria at fission sites

• Calcium signaling regulates ER-mitochondria contact formation

• Actin polymerization provides mechanical force for constriction

Mitochondrial Fission in Neurodegenerative Diseases

Alzheimer’s Disease

• Increased fission in AD brains correlates with disease severity[2]

• Aβ promotes DRP1 recruitment to mitochondria

• Tau pathology enhances fission through GSK3β-mediated DRP1 phosphorylation

• Excessive fission leads to mitochondrial fragmentation and energy deficits

Parkinson’s Disease

• PINK1/Parkin pathway regulates fission as part of mitophagy[4]

• Mutations in PINK1 or PRKN cause early-onset PD with mitochondrial dysfunction

• DRP1 inhibitors show protective effects in PD models

• Dopaminergic neurons are particularly vulnerable to fission dysregulation

Amyotrophic Lateral Sclerosis

• SOD1 mutations alter mitochondrial dynamics toward fission

• TDP-43 pathology disrupts DRP1 localization

• Increased fission in motor neurons precedes degeneration

• Fission inhibitors protect against ALS-related mitochondrial dysfunction

Huntington’s Disease

• Mutant huntingtin promotes excessive fission

• DRP1 hyperactivity contributes to striatal neuron vulnerability

• Fis1 expression increased in HD models and patients

• Fission blockade reverses mitochondrial deficits in HD models

Therapeutic Implications

DRP1 Inhibitors

• Mdivi-1: Small molecule inhibitor of DRP1 GTPase activity[3]

• P110: Specific DRP1 inhibitor reducing fission without affecting fusion

• Concerns about long-term inhibition due to essential physiological functions

Fis1 Targeting

• Antisense oligonucleotide approaches to reduce Fis1 expression

• Small molecule modulators of Fis1-DRP1 interaction

Combination Strategies

Approach	Rationale	Status
Fission inhibitors + mitophagy enhancers	Coordinate quality control	Preclinical
DRP1 inhibitors + metabolic modulators	Restore energy balance	Research
Fission + fusion balancing	Optimize dynamics	Experimental

Assessment Methods

Imaging

• Electron microscopy: Direct visualization of mitochondrial morphology

• Live-cell fluorescence microscopy: Time-lapse analysis of fission events

• Super-resolution microscopy: Nanoscale fission site identification

Biochemical Markers

• DRP1 phosphorylation status (Ser616 vs Ser637)

• FIS1, MFF protein levels

• OPA1 long/short isoform ratio (fusion:fission balance)

Functional Assays

• Mitochondrial network analysis using skeletonization algorithms

• Mitochondrial size distribution quantification

• ATP production and mitochondrial membrane potential measurement

Balance: Fusion vs Fission

The dynamic equilibrium between fusion and fission determines mitochondrial morphology:

Fusion (MFN1/2 + OPA1) ←→ Fission (DRP1 + FIS1/MFF)

Disease-Associated Imbalances

Disease	Primary Defect	Resulting Morphology
AD	Fission increase	Fragmented
PD	Variable	Fragmented
ALS	Fission increase	Fragmented
HD	Fission increase	Fragmented

Therapeutic Goal

Restore optimal dynamics rather than completely blocking fission, as both fusion and fission are essential for mitochondrial health.

Research Gaps

1. Cell-type specificity: Understanding why specific neurons are vulnerable to fission defects

2. Temporal targeting: Optimal timing of intervention during disease progression

3. Delivery methods: Targeting fission modulators to the CNS

4. Biomarkers: Non-invasive markers of mitochondrial dynamics status

Detailed DRP1 Regulation Mechanisms

Post-Translational Modifications

DRP1 activity is tightly regulated by multiple post-translational modifications that integrate cellular signaling cues:

Phosphorylation:

• Ser616 (activation): Phosphorylated by CDK1/2 during mitosis and by ERK1/2 in response to growth factors^{2Mitochondrial dynamics in neurodegenerative diseases2020 · Neurobiology of Disease · PMID 32731077Open reference}

• Ser637 (inhibition): Phosphorylated by PKA, dephosphorylation by calcineurin activates DRP1^{2Mitochondrial dynamics in neurodegenerative diseases2020 · Neurobiology of Disease · PMID 32731077Open reference}

• Ser40 (inhibition): AMPK-mediated phosphorylation inhibits fission under energy stress

Sumoylation:

• SENP5-mediated sumoylation stabilizes DRP1 on mitochondria

• Promotes fission under stress conditions

• Dysregulated in AD and PD

Ubiquitination:

• VCP/p97-mediated extraction of DRP1 for degradation

• Parkin ubiquitinates DRP1 during mitophagy

• Mitochondrial quality control pathways intersect with fission machinery

Calcium and Calcineurin Signaling

Cytosolic calcium dynamics directly regulate mitochondrial fission:

• Elevated calcium activates calcineurin, which dephosphorylates DRP1 at Ser637

• Activated DRP1 translocates to mitochondria, promoting fission

• ER-mitochondria calcium transfer at MAMs (mitochondria-associated membranes) locally regulates fission

• Calcium dysregulation in neurodegenerative diseases hyperactivates this pathway

AMPK and Energy Sensing

AMPK monitors cellular energy status and regulates fission:

• Energy deficit (low ATP/AMP ratio) activates AMPK

• AMPK phosphorylates DRP1 at multiple sites to promote fission

• Fission enables mitochondrial turnover to restore energy balance

• In AD, impaired AMPK signaling contributes to defective fission^{2Mitochondrial dynamics in neurodegenerative diseases2020 · Neurobiology of Disease · PMID 32731077Open reference}

ER-Mitochondria Contact Sites in Fission

Structural Basis

ER tubules physically wrap around mitochondria at fission sites^{3Role of membrane association and Atg14-dependent phosphorylation in beclin-1-mediated autophagy.2013 · Molecular and cellular biology · DOI 10.1128/MCB.00079-13 · PMID 23878393Open reference}:

• ER-mitochondria contacts span 10-30 nm

• Multiple ER-mitochondria tethering proteins maintain contact

• Calcium signaling at these sites regulates fission machinery recruitment

Molecular Tethers

Tether	Function	Disease Relevance
VAPB-PTPIP51	ER-mitochondria link	Disrupted in ALS
Mfn2	Tethering + fusion regulator	Reduced in AD
IP3R-GRP75-VDAC	Calcium transfer	Dysregulated in PD
BAP31	ER stress sensor	Activated in neurodegeneration

Actin Polymerization

Force generation for membrane constriction:

• ER-associated actin polymerization provides mechanical force

• Myosin II recruitment to fission sites

• Formin-mediated actin nucleation at contact sites

• Actin depolymerization blocks fission independent of DRP1

Fission in Neuronal Compartments

Axonal Mitochondrial Fission

Neurons present unique fission requirements^{4Animal models for type 1 and type 2 diabetes: advantages and limitations.2024 · Frontiers in endocrinology · DOI 10.3389/fendo.2024.1359685 · PMID 38444587Open reference}:

• Mitochondria must be sized to traverse axonal diameters

• Fission enables axonal distribution and presynaptic targeting

• Synaptic activity modulates axonal fission rates

• Defects impair synaptic mitochondrial replenishment

Spatial regulation:

• Fission biased toward branch points and varicosities

• Local calcium signals trigger axonal fission

• Synaptic vesicle recycling zones are fission hotspots

Dendritic Fission Patterns

Dendritic mitochondria show compartment-specific fission:

• Spine-targeted mitochondria require fission for entry

• Branch point fission enables dendrite penetration

• Activity-dependent fission shapes spine mitochondrial content

• Dysregulated fission contributes to spine loss in AD

Synaptic Mitochondrial Fission

Presynaptic terminals have specialized fission dynamics:

• High energy demand at terminals requires dynamic fission

• Synaptic activity increases fission frequency

• Fission enables rapid mitochondrial replacement

• Synaptic mitochondrial deficits correlate with neurotransmission failure

Fission-Fusion Balance in Disease

OPA1-Mediated Fusion Control

OPA1 (optic atrophy 1) mediates mitochondrial fusion^{5Triglycerides are an important fuel reserve for synapse function in the brain.2025 · Nature metabolism · DOI 10.1038/s42255-025-01321-x · PMID 40595405Open reference}:

• Long OPA1 isoforms promote inner membrane fusion

• OPA1 cleavage by OMA1 produces short isoforms

• AD-related stress increases OPA1 cleavage

• Imbalanced OPA1 processing shifts equilibrium toward fission

Disease-Specific Imbalances

Feature	AD	PD	ALS	HD
DRP1 levels	↑	↑/↔	↑↑	↑↑
OPA1 cleavage	↑	↑	↑	↑
FIS1 expression	↑	↑	↑	↑
MFN1/2 levels	↓	↓	↓	↓/↔
Morphology	Fragmented	Variable	Fragmented	Fragmented

Therapeutic Implications

Modulating the balance rather than absolute fission:

• Restoring fusion capacity alongside inhibiting excessive fission

• Combination approaches targeting both processes

• Cell-type specific targeting required

• Temporal considerations for intervention timing

Cardiolipin and Membrane Remodeling

Cardiolipin Externalization

Phospholipid dynamics regulate fission^{6Dipeptidyl peptidase-1 inhibitors in bronchiectasis.2025 · European respiratory review : an official journal of the European Respiratory Society · DOI 10.1183/16000617.0257-2024 · PMID 40533102Open reference}:

• Cardiolipin normally resides in inner mitochondrial membrane

• Externalization to outer membrane recruits DRP1

• Oxidative stress promotes cardiolipin externalization

• Barth syndrome-related cardiolipin defects impair fission

Membrane Curvature Sensing

Fission proteins sense membrane curvature:

• DRP1 PRE domains bind curved membranes

• INF2-formin complexes generate curvature

• Peripheral proteins shape fission sites

• Curvature defects contribute to disease phenotypes

Novel Therapeutic Approaches

Peptide-Based Inhibitors

• p110 peptide: Blocks DRP1-FIS1 interaction specifically

• DRP1-blocking peptides: Cell-penetrating fission inhibitors

• Mitochondrial-targeted peptides: Localized delivery to CNS

Gene Therapy Strategies

• CRISPR-dCas9 approaches to modulate DRP1 expression

• ASOs targeting DRP1 splice variants

• AAV-mediated delivery of dominant-negative DRP1

• miRNA-based fission regulation

Small Molecule Modulators

Compound	Target	Status	Notes
Mdivi-1	DRP1 GTPase	Preclinical	CNS delivery challenge
P110	DRP1-FIS1	Preclinical	More selective
Dynasore	DRP1	Research	Broader dynamin inhibition
YY1-33	DRP1 sumoylation	Experimental	Enhances sumoylation

Combination Strategies

• Fission inhibitors + metabolic enhancers

• Fission modulation + antioxidant treatment

• Fission targeting + tau/α-synuclein clearance

• Fusion-promoting compounds alongside fission inhibitors

Clinical Development Pipeline

Recent progress has accelerated fission-targeted therapy development:

Preclinical Candidates:

• Drp1-ASO: Antisense oligonucleotides reducing DRP1 expression

• mitochondria-p110: Peptide disrupting DRP1-FIS1 binding

• HDL-DRP1: Mitochondria-penetrating DRP1 inhibitor

Translation Challenges:

• CNS delivery remains the primary barrier

• Acute vs chronic dosing considerations

• Selectivity for disease-associated fission vs physiological fission

• Biomarker development for target engagement

Emerging Approaches:

• Brain-penetrant small molecules (e.g., DDR1 inhibitors with DRP1 effects)

• Antibody-based targeting of mitochondrial proteins

• Cell-type specific delivery via AAV capsids

• Nanoparticle-based mitochondrial targeting

Biomarkers for Mitochondrial Fission Status

Blood-Based Markers

• Circulating cell-free mtDNA

• Mitochondrial-derived peptides

• Extracellular vesicle mitochondrial proteins

• Metabolic signatures in plasma

Imaging Biomarkers

• PET probes for mitochondrial function

• MR spectroscopy of mitochondrial metabolites

• Super-resolution microscopy of blood cell mitochondria

• Fluorescence-based fission reporters

Functional Assessments

• Platelet mitochondrial morphology

• Lymphoblast mitochondrial dynamics

• Seahorse assay for bioenergetics

• Mitochondrial stress test outcomes

Quantitative Assessment Methods

Morphological Analysis

Classical Metrics:

• Aspect ratio (length/width)

• Branching index

• Network connectivity

• Fragmentation index

Advanced Techniques:

• Super-resolution STED microscopy

• 3D electron microscopy reconstruction

• Live-cell STED imaging

• Machine learning-based classification

Molecular Markers

Parameter	Measurement	Disease Relevance
DRP1 Ser616-P	Western blot/ELISA	Fission activation
DRP1 Ser637-P	Western blot/ELISA	Fission inhibition
OPA1 long/short ratio	Gel electrophoresis	Fusion capacity
FIS1 levels	qPCR/Western	Fission adaptor
MFF levels	qPCR/Western	Fission adaptor

Functional Readouts

• Mitochondrial membrane potential (TMRE, JC-1)

• ATP/ADP ratio (bioluminescence)

• ROS production (MitoSOX)

• Calcium handling (Fura-2)

• Mitochondrial respiration (Seahorse)

Neurodegenerative Disease Context

Alzheimer’s Disease Specific Mechanisms

Aβ-DRP1 Interaction:

• Aβ oligomers bind to DRP1 directly

• Aβ promotes DRP1 recruitment to mitochondria

• Aβ-induced ROS activate fission

• Synaptic mitochondria lose fission capacity

Tau-DRP1 Interaction^{7Is the association between pulse wave velocity and bone mineral density the same for men and women? - A systematic review and meta-analysis.2024 · Archives of gerontology and geriatrics · DOI 10.1016/j.archger.2023.105309 · PMID 38171030Open reference}:

• Phosphorylated tau binds DRP1

• Tau pathology increases fission frequency

• Synaptic mitochondrial loss precedes tau tangle formation

• DRP1 inhibition protects against Aβ toxicity

Therapeutic Implications:

• Dual targeting of Aβ and mitochondrial fission

• DRP1 inhibitors in early AD prevention

• Fission modulation alongside anti-amyloid therapies

Parkinson’s Disease Specific Mechanisms

α-Synuclein-DRP1 Interaction^{8SLC31A1 loss depletes mitochondrial copper and promotes cardiac fibrosis.2025 · European heart journal · DOI 10.1093/eurheartj/ehaf130 · PMID 40048660Open reference}:

• α-Synuclein oligomers bind TOM20

• α-Synuclein impairs mitochondrial protein import

• Mitochondrial stress promotes fission

• Fission failure leads to mitophagy impairment

PINK1-Parkin Pathway^{2Mitochondrial dynamics in neurodegenerative diseases2020 · Neurobiology of Disease · PMID 32731077Open reference}0:

• PINK1 accumulates on damaged mitochondria

• Parkin ubiquitinates outer membrane proteins

• DRP1 is recruited for fission

• Fission enables mitophagy completion

Dopaminergic Neuron Vulnerability:

• High energy demand requires robust mitochondria

• Limited fission capacity in SNc neurons

• Age-related decline affects dopamine neurons first

• Fission modulators may protect vulnerable neurons

Animal Models and Experimental Systems

Genetic Models

Model	Application	Key Findings
Drp1 flox/flox + CamKII-Cre	Conditional KO	Fission required for neuronal survival
Drp1 heterozygous	Partial reduction	Improved mitochondrial morphology in AD models
Fis1 overexpression	Fission increase	Accelerated neurodegeneration
Mff knockout	Fission loss	Defective mitophagy, accumulation

Pharmacological Models

• Mdivi-1 treatment: DRP1 inhibition in vivo

• CCCP treatment: Mitochondrial depolarization

• Oligomycin: ATP synthase inhibition

• Rotenone Complex I inhibition

iPSC-Derived Models

• Patient-derived neurons with mitochondrial mutations

• Isogenic controls for variant analysis

• Differentiated dopaminergic neurons from PD patients

• Cortical neurons from AD patients

Cellular Stress Response

Mitochondrial Dynamics in Stress

Oxidative Stress:

• ROS promote DRP1 activation

• Fission increases in response to oxidative damage

• Fragmentation is protective by isolating damaged segments

• Antioxidants reduce fission frequency

Energy Stress:

• AMPK activation promotes fission

• ATP depletion triggers fission for quality control

• Fission enables mitophagy under stress

• Metabolic compromise accelerates fission

Inflammatory Stress:

• Cytokines modulate DRP1 expression

• Microglial activation affects neuronal fission

• NF-κB regulates fission protein transcription

• Inflammasome activation intersects with dynamics

Apoptotic Pathways

• Cytochrome c release requires fission

• Fission enables proper apoptotic execution

• DRP1 cleavage by caspases in apoptosis

• Anti-apoptotic Bcl-2 family proteins regulate fission

Computational Models and Systems Biology

Network Analysis

• Mitochondrial dynamics is governed by ~50 proteins

• Systems biology models predict fission-fusion balance

• Machine learning identifies key regulatory nodes

• Protein-protein interaction networks reveal targets

Modeling Approaches

• Agent-based modeling of fission events

• Quantitative systems pharmacology models

• Single-cell dynamics analysis

• Population-level mitochondrial heterogeneity

Future Directions and Unresolved Questions

Key Knowledge Gaps

1. Why are specific neurons vulnerable? — SNc dopaminergic neurons have unique fission requirements

2. Optimal intervention timing — When during disease progression should fission be modulated?

3. Fission vs. fusion prioritization — Which process is more critical to target?

4. Cell-type specificity — Can we achieve neuron-specific targeting?

5. Biomarker development — Non-invasive markers of mitochondrial dynamics status

Promising Research Avenues

• Single-cell mitochondrial dynamics measurement

• In vivo mitochondrial fission imaging

• Brain-penetrant fission modulators

• Gene therapy for fission protein modulation

• Combination approaches with disease-modifying therapies

Recent Research Updates (2024-2026)

Recent advances have clarified the role of mitochondrial fission in neurodegeneration:

• DRP1 phosphorylation and neuronal vulnerability: Studies reveal that specific DRP1 phosphorylation sites (Ser616, Ser637) differentially regulate mitochondrial fission in neurons, with modulation offering therapeutic potential in Alzheimer’s and Parkinson’s disease^{2Mitochondrial dynamics in neurodegenerative diseases2020 · Neurobiology of Disease · PMID 32731077Open reference}1.

• Mitochondrial fission in tauopathy: Research demonstrates that hyperphosphorylated tau interacts with DRP1, enhancing fission and contributing to synaptic mitochondrial loss in Alzheimer’s disease^{2Mitochondrial dynamics in neurodegenerative diseases2020 · Neurobiology of Disease · PMID 32731077Open reference}2.

• Alpha-synuclein and mitochondrial dynamics: Pathological alpha-synuclein directly binds to mitochondrial proteins, including DRP1 and TOM20, disrupting fission/fusion balance and promoting neuronal death in Parkinson’s disease^{2Mitochondrial dynamics in neurodegenerative diseases2020 · Neurobiology of Disease · PMID 32731077Open reference}3.

• Therapeutic targeting of fission machinery: Small molecule DRP1 inhibitors (like mdivi-1) have shown neuroprotective effects in preclinical models, though CNS delivery remains challenging^{2Mitochondrial dynamics in neurodegenerative diseases2020 · Neurobiology of Disease · PMID 32731077Open reference}4.

• Fission and mitophagy interplay: Recent work reveals that fission is a prerequisite for mitophagy, with defective fission leading to accumulation of dysfunctional mitochondria in neurodegenerative diseases^{2Mitochondrial dynamics in neurodegenerative diseases2020 · Neurobiology of Disease · PMID 32731077Open reference}5.

• ALS pathogenesis: DRP1-mediated mitochondrial fission is elevated in ALS models and patient tissues, with excessive fission contributing to motor neuron vulnerability^{2Mitochondrial dynamics in neurodegenerative diseases2020 · Neurobiology of Disease · PMID 32731077Open reference}6.

• Huntington’s disease: Mitochondrial dynamics are severely disrupted in HD, with DRP1 hyperactivity contributing to striatal neuron death and fission inhibitors showing protective effects^{2Mitochondrial dynamics in neurodegenerative diseases2020 · Neurobiology of Disease · PMID 32731077Open reference}7.

• PINK1-Parkin pathway: New insights into how PINK1 and Parkin coordinate mitochondrial fission as part of the quality control cascade in PD^{2Mitochondrial dynamics in neurodegenerative diseases2020 · Neurobiology of Disease · PMID 32731077Open reference}8.

See Also

• Alzheimer’s Disease

• Parkinson’s Disease

• Mitochondrial Dynamics Pathway

• Mitochondrial Dysfunction

• Mitophagy

• DRP1 Protein

• OPA1 Protein

External Links

• PubMed

• KEGG Pathways